Effect of Valsartan on Quality of Life When Added to Usual Therapy for Heart Failure: Results From The Valsartan Heart Failure Trial
- 1 May 2005
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Cardiac Failure
- Vol. 11 (4), 253-259
- https://doi.org/10.1016/j.cardfail.2004.11.004
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Preferences for quality of life or survival expressed by patients with heart failureThe Journal of Heart and Lung Transplantation, 2001
- Health-related quality of life measurement in heart failure: Challenges for the new millenniumJournal of Cardiac Failure, 2001
- Measuring quality of life: Using quality of life measures in the clinical settingBMJ, 2001
- Health-Related Quality-of-Life Measurement in HypertensionPharmacoEconomics, 2000
- Comparative responsiveness of Short-Form 12 and Minnesota Living With Heart Failure Questionnaire in patients with heart failure.Journal of Cardiac Failure, 2000
- Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart FailureThe American Journal of Cardiology, 1996
- Use of the living with heart failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced deathJournal of Cardiac Failure, 1995
- Validity of the minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placeboThe American Journal of Cardiology, 1993
- Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendanAmerican Heart Journal, 1992